<DOC>
	<DOC>NCT00986856</DOC>
	<brief_summary>To investigate the clinical and bacteriological efficacy of Fucidin速 cream in the treatment of impetigo in paediatric patients. To assess the validity of in vitro susceptibility-testing of S. aureus to fusidic acid as a prediction of clinical and bacteriological outcome in impetigo patients treated with Fucidin速 cream. To investigate the genetic relationship between S. aureus-strains isolated from impetigo patients.</brief_summary>
	<brief_title>Fucidin速 Cream in the Treatment of Impetigo</brief_title>
	<detailed_description />
	<mesh_term>Impetigo</mesh_term>
	<mesh_term>Fusidic Acid</mesh_term>
	<criteria>Patients with a clinical diagnosis of impetigo, Patients aged 211 years, Patients of either sex, Patients whose parent(s) has(ve) provided written consent, AND Patients with a severity score of 1 for at least one of the following signs: pustules/infected bullae, erythema and infiltration/induration. Patients with other active inflammatory dermatitis at the area of impetigo, Patients with a temperature above 38.5 C rectally (or equivalent), OR Patients who have been administered topical or systemic Fucidin速 or other antibacterial agents within the previous 4 weeks.</criteria>
	<gender>All</gender>
	<minimum_age>2 Years</minimum_age>
	<maximum_age>11 Years</maximum_age>
	<verification_date>March 2015</verification_date>
</DOC>